SCHEMBL8876707

SCHEMBL8876707

CC1(O)CCC(=O)N1Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
GAA P10253 3/20 0.45
ELANE P08246 1/20 0.45
AMPD2 Q01433 2/20 0.44
TSHR P16473 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
EPHX2 P34913 1/20 0.41
OPRL1 P41146 1/20 0.41
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
STAT6 P42226 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14828734 0.83 ALDH1A1 (0.49) ALDH1A1GAAELANEAMPD2TSHR
SCHEMBL3733166 0.81 TSHR (0.52) ALDH1A1GAAELANEAMPD2TSHR
SCHEMBL14828739 0.80 TSHR (0.51) ALDH1A1GAAAMPD2TSHR
SCHEMBL14665078 0.79 ELANE (0.45) ALDH1A1GAAELANEAMPD2TSHR
SCHEMBL14664013 0.78 GAA (0.43) ALDH1A1GAAELANEAMPD2TSHR
SCHEMBL22394905 0.78 HCRTR1 (0.50) GAAELANEL3MBTL1EPHX2OPRL1
SCHEMBL14665104 0.78 TSHR (0.52) ALDH1A1GAAELANEAMPD2TSHR
SCHEMBL1317310 0.77 ALDH1A1 (0.43) ALDH1A1GAATSHROPRL1CYP1A2
SCHEMBL14664096 0.77 TSHR (0.48) ALDH1A1AMPD2TSHR
SCHEMBL4460381 0.76 HCRTR1 (0.41) ALDH1A1GAAAMPD2TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964222-B1 COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY MERCK SHARP & DOHME (US) 2017-08-30 EP disclosed
US-5607933-A METHODS FOR TREATMENT OF GLAUCOMA AND FOR RELIEF OF PAIN AND RHEUMATIC AND INFLAMMATORY CONDITIONS BY ADMINISTERING THE INDOLES; N-HETERYL IS 2-PIPERAZINYL STERLING WINTHROP INC. (US) 1997-03-04 US disclosed